Aurobindo Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue7,9738,4068,8348,9709,415
Expenses6,7697,1327,4307,6777,858
EBITDA1,7081,7991,9611,8702,145
Operating Profit1,3051,3711,4311,3891,617
Profit Before Tax1,2071,2761,3391,2911,515
Net Profit824.20848.13909.80920.841,032
Financial Ratios
Operating Profit Margin21.95%21.86%22.04%21.34%23.10%
Net Profit Margin10.58%10.30%11.10%10.53%11.60%
Earning Per Share (Diluted)14.2014.6115.6715.8617.86
Dividends Per Share4.000.000.000.000.00